Clinical Features and Long-Term Outcomes in Very Young Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries

Table 4

Adverse events in the study period.

Adverse events	oCAD (n = 243)	MINOCA (n = 32)	Controls (n = 120)	value oCAD vs controls	value MINOCA vs controls	value oCAD vs MINOCA
New coronary revascularizations	34 (14.0%)	4 (12.0%)	1 (1.7%)	<0.001	0.018	1.000
Death	8 (3.3%)	2 (6.2%)	4 (3.3%)	1.000	0.607	0.330
AMI	8 (3.3%)	1 (3.1%)	1 (0.8%)	0.282	0.378	1.000
Stroke	5 (2.1%)	0 (0.0%)	1 (0.8%)	0.668	1.000	1.000
MACE	47 (19.3%)	6 (18.8%)	6 (5.0%)	<0.001	0.020	0.928

Data are given as number (percentage). oCAD, obstructive CAD. AMI, acute myocardial infarction. MACE, major adverse cardiovascular events, a composite of death, myocardial infarction, stroke, and new coronary revascularizations.